English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 12 Help

Selected(0)Clear Items/Page:    Sort:
Characterization of second primary malignancies post CAR T-cell therapy: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase Journal article
Shen, Junyi, Hu, Rong, Lin, Anqi, Jiang, Aimin, Tang, Bufu, Liu, Zaoqu, Cheng, Quan, Miao, Kai, Zhang, Jian, Luo, Peng. Characterization of second primary malignancies post CAR T-cell therapy: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase[J]. eClinicalMedicine, 2024, 73, 102684.
Authors:  Shen, Junyi;  Hu, Rong;  Lin, Anqi;  Jiang, Aimin;  Tang, Bufu; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4 | Submit date：2024/07/04
Car-t  Faers  Myelodysplastic Syndromes  Second Primary Malignancy  T-cell Lymphoma  Vigibase  
Antibody Recognition of Human Epidermal Growth Factor Receptor-2 (HER2) Juxtamembrane Domain Enhances Anti-Tumor Response of Chimeric Antigen Receptor (CAR)-T Cells Journal article
Zhou, Guangyu, Fu, Shengyu, Zhang, Yunsen, Li, Shuang, Guo, Ziang, Ouyang, Defang, Ying, Tianlei, Lu, Yinying, Zhao, Qi. Antibody Recognition of Human Epidermal Growth Factor Receptor-2 (HER2) Juxtamembrane Domain Enhances Anti-Tumor Response of Chimeric Antigen Receptor (CAR)-T Cells[J]. Antibodies, 2024, 13(2), 45.
Authors:  Zhou, Guangyu;  Fu, Shengyu;  Zhang, Yunsen;  Li, Shuang;  Guo, Ziang; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.0/4.7 | Submit date：2024/08/05
Car-t Cell  Her2  Monoclonal Antibody  Trastuzumab  
Profiling targets and potential target pairs of CAR-T cell therapy in clinical trials Journal article
Zhang, Daiyan, Lyu, Liyang, Han, Shuo, Xu, Jiaqi, Hu, Guang, Zhao, Qi, Hu Yuanjia. Profiling targets and potential target pairs of CAR-T cell therapy in clinical trials[J]. International Immunopharmacology, 2024, 126, 111273.
Authors:  Zhang, Daiyan;  Lyu, Liyang;  Han, Shuo;  Xu, Jiaqi;  Hu, Guang; et al.
Adobe PDF | Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.8/5.0 | Submit date：2024/01/02
Car-t  Clinical Trials  Dual-target  Target Profiling  
Programmed death-ligand 1 expression on CD22-specific chimeric antigen receptor-modified T cells weakens antitumor potential Journal article
Liu, Jie, Zhang, Fengjuan, Yu, Jian, Zhao, Qi. Programmed death-ligand 1 expression on CD22-specific chimeric antigen receptor-modified T cells weakens antitumor potential[J]. MedComm, 2022, 3(2).
Authors:  Liu, Jie;  Zhang, Fengjuan;  Yu, Jian;  Zhao, Qi
Favorite | TC[WOS]:4 TC[Scopus]:3 | Submit date：2022/08/02
Car-t  Cd22  Immune Checkpoint  Pd-l1  
Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes Journal article
Liu, Jie, Yang, Shuo, Cao, Bihui, Zhou, Guangyu, Zhang, Fengjuan, Wang, Yuan, Wang, Rixin, Zhu, Lipeng, Meng, Ya, Hu, Cong, Liang, Hui, Lin, Xu, Zhu, Kangshun, Chen, Guokai, Luo, Kathy Qian, Di, Lijun, Zhao, Qi. Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes[J]. Journal of Hematology and Oncology, 2021, 14(1), 1-18.
Authors:  Liu, Jie;  Yang, Shuo;  Cao, Bihui;  Zhou, Guangyu;  Zhang, Fengjuan; et al.
Favorite | TC[WOS]:60 TC[Scopus]:64  IF:29.5/26.9 | Submit date：2021/03/04
B7-h3  Bike  Bispecific Antibody  Car t  Chimeric Antigen Receptor  Non-small Cell Lung Cancer  Pd-l1  
Nanomedicine-combined immunotherapy for cancer Journal article
Shigao Huang, Qi Zhao. Nanomedicine-combined immunotherapy for cancer[J]. CURRENT MEDICINAL CHEMISTRY, 2020, 27(34), 5716-5729.
Authors:  Shigao Huang;  Qi Zhao
Favorite | TC[WOS]:23 TC[Scopus]:23  IF:3.5/4.0 | Submit date：2021/03/04
(Car)-t Cells  Cancer Immunotherapy  Car-nk Cells  Drug Delivery  Nanomedicine  Synergistic Effect  
Novel chimeric antigen receptor T cells based on T-cell receptor-like antibodies Journal article
Zhao, Q.. Novel chimeric antigen receptor T cells based on T-cell receptor-like antibodies[J]. Blood Science, 2019, 144-147.
Authors:  Zhao, Q.
Favorite |   IF:1.5/1.4 | Submit date：2023/08/25
Antibody  CAR  T cell  TCR-like antibody  
Assessment of chimeric antigen receptor T (CAR-T) cell cytotoxicity using droplet microflluidics Conference paper
Wang, Haitao, Wong, Johnny Kuan Un, Shi, Jingxuan, Jia,Yanwei, Deng,Chuxia, Jiang, Lianmei, Li, Peng, Wong, Ada Hang Heng. Assessment of chimeric antigen receptor T (CAR-T) cell cytotoxicity using droplet microflluidics[C], 2019, 1594-1595.
Authors:  Wang, Haitao;  Wong, Johnny Kuan Un;  Shi, Jingxuan;  Jia,Yanwei;  Deng,Chuxia; et al.
Favorite | TC[Scopus]:1 | Submit date：2021/03/02
Car-t  Droplet Microfluidics  Immunotherapy  Precision Cancer Therapy  
Novel chimeric antigen receptor T cells based on T-cell receptor-like antibodies Journal article
Zhao, Qi. Novel chimeric antigen receptor T cells based on T-cell receptor-like antibodies[J]. Blood Science, 2019, 1(2), 144-147.
Authors:  Zhao, Qi
Favorite | TC[WOS]:5 TC[Scopus]:5  IF:1.5/1.4 | Submit date：2022/08/27
Antibody  Car  t Cell  Tcr-like Antibody  
Building potent chimeric antigen receptor T cells with CRISPR genome editing Journal article
Liu, J., Zhou, G., Zhang, L., Zhao, Q.. Building potent chimeric antigen receptor T cells with CRISPR genome editing[J]. Frontiers in Immunology, 2019, 456-456.
Authors:  Liu, J.;  Zhou, G.;  Zhang, L.;  Zhao, Q.
Favorite |   IF:5.7/6.8 | Submit date：2023/08/25
chimeric antigen receptor  CRISPR  gene editing  immunotherapy  cancer  CAR T